Computer glitch in insulin pumps hits MiniMed shares
This article was originally published in Clinica
Executive Summary
MiniMed has warned that a software error in some of its insulin pumps could lead to unreliable insulin dosing. The company said that only certain of its Model 508 pumps, manufactured between October 4 and November 18, are affected. The fault will cost the company up to $1.5 million to upgrade the relevant software. MiniMed saw more than $10 wiped from its share price on the announcement, with its shares ending early last Tuesday at $79.20.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.